Diagnosis and management of heart failure from hospital admission to discharge: A practical expert guidance.

Acute heart failure Approche multidisciplinaire Comorbidities Comorbidités Discharge Guide pratique Heart failure Heart failure management Insuffisance cardiaque Insuffisance cardiaque aiguë Multidisciplinary approach Optimisation du traitement Parcours patient Pathway Practical guide Prise en charge de l’insuffisance cardiaque Treatment optimization Écoulement

Journal

Annales de cardiologie et d'angeiologie
ISSN: 1768-3181
Titre abrégé: Ann Cardiol Angeiol (Paris)
Pays: France
ID NLM: 0142167

Informations de publication

Date de publication:
Feb 2022
Historique:
received: 25 02 2021
accepted: 07 05 2021
pubmed: 19 7 2021
medline: 4 2 2022
entrez: 18 7 2021
Statut: ppublish

Résumé

Heart failure (HF) has high event rates, mortality, and is challenging to manage in clinical practice. Clinical management is complicated by complex therapeutic strategies in a population with a high prevalence of comorbidity and general frailty. In the last four years, an abundance of research has become available to support multidisciplinary management of heart failure from within the hospital through to discharge and primary care as well as supporting diagnosis and comorbidity management. Within the hospital setting, recent evidence supports sacubitril-valsartan combination in frail, deteriorating or de novo patients with LVEF≤40%. Furthermore, new strategies such as SGLT2 inhibitors and vericiguat provide further benefit for patients with decompensating HF. Studies with tafamidis report major clinical benefits specifically for patients with ATTR cardiac amyloidosis, a remaining underdiagnosed and undertreated disease. New evidence for medical interventions supports his bundle pacing to reduce QRS width and improve haemodynamics as well as ICD defibrillation for non-ischemic cardiomyopathy. The Mitraclip reduces hospitalisations and mortality in patients with symptomatic, secondary mitral regurgitation and ablation reduces mortality and hospitalisations in patients with paroxysmal and persistent atrial fibrillation. In end-stage HF, the 2018 French Heart Allocation policy should improve access to heart transplants for stable, ambulatory patients and, mechanical circulatory support should be considered to avoid deteriorating on the waiting list. In the community, new evidence supports that improving discharge education, treatment and patient support improves outcomes. The authors believe that this review fills the gap between the guidelines and clinical practice and provides practical recommendations to improve HF management.

Identifiants

pubmed: 34274113
pii: S0003-3928(21)00068-8
doi: 10.1016/j.ancard.2021.05.004
pii:
doi:

Substances chimiques

Aminobutyrates 0
Biphenyl Compounds 0
sacubitril 17ERJ0MKGI

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

41-52

Informations de copyright

Copyright © 2021 Elsevier Masson SAS. All rights reserved.

Auteurs

P Sabouret (P)

Heart Institute, Cardiology department, La Pitié Salpetrière Hospital, Sorbonne University, Paris, France.

D Attias (D)

Cardiology department, Centre Cardiologique du Nord, Saint-Denis, France.

C Beauvais (C)

Cardiology department, La Riboisière Hospital, Inserm UMRS 942, University of Paris, Paris, France.

E Berthelot (E)

Cardiology department, Kremlin Bicêtre Hospital, Paris-Saclay University, Le Kremlin Bicêtre, France.

C Bouleti (C)

Cardiology department, Poitiers University Hospital, CIC INSERM 1402, Poitiers, France.

G Gibault Genty (G)

Cardiology department, André Mignot Hospital, Le Chesnay, France.

A Galat (A)

Cardiology department, University Hospital Henri Mondor, UPEC, Créteil, France.

O Hanon (O)

Geriatrics Department, Hospital Broca, Paris Descartes University, Paris, France.

J S Hulot (JS)

Pharmacology Department, Georges-Pompidou European Hospital, INSERM, PARCC, CIC1418 Paris-Descartes University, Paris, France.

R Isnard (R)

Heart Institute, Cardiology department, La Pitié Salpetrière Hospital, Sorbonne University, Paris, France.

P Jourdain (P)

Cardiology department, Kremlin Bicêtre Hospital, Paris-Saclay University, Le Kremlin Bicêtre, France.

N Lamblin (N)

Cardiology Department, University Hospital, Lille, France.

G Lebreton (G)

Heart Institute, Cardiac Surgery department, La Pitié Salpêtrière Hospital, Sorbonne University, Paris, France.

N Lellouche (N)

Cardiology department, University Hospital Henri Mondor, UPEC, Créteil, France.

D Logeart (D)

Cardiology department, La Riboisière Hospital, Inserm UMRS 942, University of Paris, Paris, France.

C Meune (C)

Department of Cardiology, Avicenne Hospital, Paris 13 University, Bobigny, France.

T Pezel (T)

Cardiology department, La Riboisière Hospital, Inserm UMRS 942, University of Paris, Paris, France.

T Damy (T)

Cardiology department, University Hospital Henri Mondor, UPEC, Créteil, France. Electronic address: thibaud.damy@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH